US Neurological Disorder Drugs Market is anticipated to grow significantly over the forecast period. The rising prevalence of neurological disorders coupled with the rising geriatric population tends to drive the growth of the market. In addition, the launch of novel products by the key players across the globe further supports the growth of the market. For instance, in December 2019, Ubrelvy, a novel drug manufactured by Allergan Plc was approved by the US FDA for the treatment of neurological disorders including migraine. With the introduction of a novel drug, the company strengthened its product portfolio.
US neurological disorder drugs market is segmented on the basis of disorder type into Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington disease, and others. Amongst the disorder type segment, Parkinson’s disease segment is projected to hold a lucrative share in the market. The segmental growth of the market is attributed to the increased prevalence of Parkinson’s disease among people across the globe. A broad range of drugs is used for the treatment of neurological disorders, some of which include analgesics, antihypertensive, anticholinergic, hypnotic & sedatives, and others.
To Request a Free Sample of our US Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/us-neurological-disorder-drugs-market
Market Coverage
- Market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered- By Disorder Type
- Country Covered- US
- Competitive Landscape- Eli Lilly and Co., Merck & Co. Inc., Abbvie Inc., Apotex Inc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and Amgen Inc.
US Neurological Disorder Drugs Market – Segmentation
By Disorder Type
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Huntington Disease
- Others
A full Report of US Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-neurological-disorder-drugs-market
Company Profiles
- AbbVie Inc.
- ACADIA Pharmaceuticals Inc.
- ApotexInc.
- Allergan Plc
- Amgen Inc.
- AstraZeneca Plc
- Biogen Inc.
- Eli Lilly and Co.
- Merck & Co. Inc.
- Pfizer Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-neurological-disorder-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
